Helicobacter Pylori Diagnostics Market - Size, Share, Growth, Outlook, and Opportunity Analysis, 2018-2026 Helicobacter pylori is a bacteria that resides on the lining of human stomach. Helicobacter produces chemicals, causing inflammation of stomach, which progresses to peptic ulcer or gastric cancer. Helicobacter pylori infection can be detected by simple and accurate tests such as breath test, blood tests, endoscopy, and stool tests. Based on the sample preparation, helicobacter pylori diagnostic assays are segmented into invasive methods, which includes immunoassay, rapid urease test, and histology, and Non-invasive methods, which includes stool antigen assay, serology test and urease breath test. Increasing infection prevalence in emerging economies and high demand for point-ofcare testing are major factors driving growth of Helicobacter pylori diagnostics market. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1874 Market players are investing in developing point-of-care and accurate diagnostics products to gain competitive advantage. For instance, in 2017, Exaleza Bioscience launched Automated BreathID Hp Lab Urea Breath Testing System for detection of Helicobacter pylori. The system is point-of-care, with 99% sensitivity and specificity for H. pylori. Furthermore, companies are focusing enhancing product portfolio through inorganic growth strategies. For instance, Abbott Laboratories acquired Alere Inc., the global leader in point of care diagnostics, in order to expand its product portfolio and geographic presence. With this acquisition, Abbott could access to Alere’s rapid diagnostics segment, which includes H. pylori detection kits. However, limitations associated with the currently available diagnostic assays are expected to restrain the Helicobacter pylori diagnostics market. For instance, urea breath test and stool antigen test cannot be used in patients undergoing proton pump inhibitors treatment. Helicobacter is a spiral shaped gram-negative bacteria, causing chronic inflammation and infection in stomach and duodenum leading to ulceration. H. pylori is found in 50-80% of patients with gastric ulcers and in 90% of patients with duodenal ulcers. An estimated one in six individuals infected with H. pylori are expected to eventually develop peptic ulcer disease. Infected individuals experience long asymptomatic conditions with nearly 70% of individuals having minimal symptoms such as belching, bloating, nausea, vomiting, abdominal discomfort as occasional, whereas, major symptoms includes abdominal pain, peptic ulcer, bad breath etc. Helicobacter infection can be diagnosed by invasive that requires gastric mucosa samples, which are obtained through endoscopy and used for biopsy or non-invasive tests that requires blood or stool samples. Invasive tests include immunoassay, rapid urease test, and histology whereas non-invasive includes stool antigen assays serology tests and urea breath test. Report includes chapters which deeply display the following deliverable about industry : • Helicobacter Pylori Diagnostics Market Research Objective and Assumption • Helicobacter Pylori Diagnostics Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Helicobacter Pylori Diagnostics Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Helicobacter Pylori Diagnostics Market, By Regions • Helicobacter Pylori Diagnostics Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Helicobacter Pylori Diagnostics Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Helicobacter Pylori Diagnostics Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Helicobacter Pylori Diagnostics Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Inorganic strategies by key players is fuelling growth of the Helicobacter pylori diagnostics market Key players involved in the global Helicobacter pylori diagnostics market include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories Inc., Diasorin S.P.A., Quidel Corporation, F. Hoffmann-La Roche Ltd.(Ventana Medical Systems, Inc.), Meridian Bioscience, Inc., Exalenz Bioscience Ltd., Abbott Laboratories, Cardinal Health, Inc., and Halyard Health, Inc. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/1874 Detailed Segmentation: • Global Helicobacter Pylori Diagnostics Market, By Test Type: • Invasive • Immunoassay • Rapid Urease Test • Histology • Non-invasive • Stool Antigen Assays • Serology Tests • Urea Breath Test • Global Helicobacter Pylori Diagnostics Market, By End User: • Hospitals • Clinics • Diagnostic Laboratories • Others • Global Helicobacter Pylori Diagnostics Market, By Region: • North America Helicobacter Pylori Diagnostics • Europe • Asia Pacific • Latin America • Middle East • Africa About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
© Copyright 2024 Paperzz
